Detailed Notes on active pharmaceutical ingredient manufacturers
These types of carryover should not end in the carryover of degradants or microbial contamination that may adversely alter the proven API impurity profile.Intermediate or API containers which are transported beyond the manufacturer's control need to be sealed in a very manner these that, In case the seal is breached or lacking, the recipient might